Fusion Pharmaceuticals Inc. - Common Shares (NQ:FUSN)

21.55 UNCHANGED

Last Price Updated: 4:00 PM EDT, Jun 3, 2024 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Fusion Pharmaceuticals Inc. - Common Shares

< Previous 1 2 3 4 Next >

FUSION PHARMACEUTICALS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Fusion Pharmaceuticals Inc. - FUSN

May 09, 2024

From Kahn Swick & Foti, LLC

Via Business Wire

FUSN Stock Earnings: Fusion Pharmaceuticals Misses EPS for Q1 2024 ↗

May 07, 2024

FUSN stock results show that Fusion Pharmaceuticals missed analyst estimates for earnings per share the first quarter of 2024.

Via InvestorPlace

Top 4 Health Care Stocks That May Plunge This Month ↗

April 26, 2024

Via Benzinga

Why Big Pharma Is Following Novartis' Lead In A $25 Billion Market ↗

April 25, 2024

The radiopharmaceuticals space could be worth up to $25 billion, according to one estimate.

Via Investor's Business Daily

Recap: Fusion Pharmaceuticals Q4 Earnings ↗

March 20, 2024

Via Benzinga

Unveiling 11 Analyst Insights On Fusion Pharmaceuticals ↗

March 20, 2024

Via Benzinga

Kuehn Law Encourages FUSN, KAMN, DRQ, and VZIO Investors to Contact Law Firm

March 19, 2024

--News Direct--

Via News Direct

AstraZeneca Hikes Annual Dividend By 7% Just Before Vote On Its CEO's Pay Package Boost ↗

April 11, 2024

AstraZeneca boosts its 2024 dividend to $3.10/share, reflecting confidence in performance. Shareholder concerns addressed as CEO compensation proposal approaches vote. Recent acquisitions and FDA...

Via Benzinga

AstraZeneca CEO Highlights Decade-Long Sales Goal Of $45B Along With Investor Doubts As It Lags In Weight Loss Race ↗

April 02, 2024

AstraZeneca's CEO Pascal Soriot celebrates hitting a $45 billion sales target set a decade ago despite initial skepticism. Investor confidence remains a challenge amid stagnant shares and concerns over...

Via Benzinga

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: AdTheorent Holding Company, Inc. (Nasdaq – ADTH), Agiliti, Inc. (NYSE – AGTI), Landos Biopharma, Inc. (Nasdaq – LABP), Fusion Pharmaceuticals Inc. (Nasdaq - FUSN)

April 01, 2024

From Brodsky & Smith LLC

Via GlobeNewswire

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Agiliti, Inc. (NYSE – AGTI), Landos Biopharma, Inc. (Nasdaq – LABP), Fusion Pharmaceuticals Inc. (Nasdaq - FUSN), Kinnate Biopharma Inc. (Nasdaq – KNTE)

March 25, 2024

From Brodsky & Smith LLC

Via GlobeNewswire

FUSN Stock Earnings: Fusion Pharmaceuticals Misses EPS for Q4 2023 ↗

March 20, 2024

FUSN stock results show that Fusion Pharmaceuticals missed analyst estimates for earnings per share the fourth quarter of 2023.

Via InvestorPlace

March 19, 2024

From Kahn Swick & Foti, LLC

Via Business Wire

Nasdaq Turns Higher; Caleres Posts Upbeat Q4 Results ↗

March 19, 2024

U.S. stocks traded higher toward the end of trading, with the Nasdaq Composite gaining more than 50 points on Tuesday. The Dow traded up 0.63% to 39,034.59 while the NASDAQ rose 0.35% to 16,160.20. The...

Via Benzinga

Topics Stocks

Why Peraso Shares Are Trading Lower By Over 23%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗

March 19, 2024

Shares of Peraso Inc. (NASDAQ: PRSO) fell sharply during Tuesday’s session after the company reported worse-than-expected fourth-quarter EPS results.

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

March 19, 2024

Via Benzinga

Dow Jumps 200 Points; Core & Main Shares Gain After Q4 Results ↗

March 19, 2024

U.S. stocks traded mixed midway through trading, with the Dow Jones gaining more than 200 points on Tuesday. The Dow traded up 0.54% to 39,001.22 while the NASDAQ fell 0.34% to 16,048.51. The S&P 500...

Via Benzinga

Topics Stocks

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Fusion Pharmaceuticals Inc. (Nasdaq - FUSN), Whole Earth Brands, Inc. (Nasdaq – FREE), Kinnate Biopharma Inc. (Nasdaq – KNTE), Societal CDMO Check Corp. (Nasdaq –

March 19, 2024

From Brodsky & Smith LLC

Via GlobeNewswire

National CineMedia Reports Upbeat Results, Joins Nordstrom, Core & Main And Other Big Stocks Moving Higher On Tuesday ↗

March 19, 2024

U.S. stocks were mixed, with the Dow Jones index gaining around 75 points on Tuesday.

Via Benzinga

Topics Stocks

Fusion Pharmaceuticals Inc. (NASDAQ: FUSN) Records 52-Week High Tuesday Morning

March 19, 2024

Via Investor Brand Network

Nasdaq Down 100 Points; US Housing Starts Surge In February ↗

March 19, 2024

U.S. stocks traded mixed this morning, with the Nasdaq Composite falling around 100 points on Tuesday. Following the market opening Tuesday, the Dow traded up 0.11% to 38,831.86 while the NASDAQ fell...

Via Benzinga

Topics Stocks

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

March 19, 2024

Via Benzinga

Fusion Pharma Stock Nearly Doubles After Scoring $2 Billion AstraZeneca Takeover ↗

March 19, 2024

The company is working on radiopharmaceuticals treatments for cancer.

Via Investor's Business Daily

Why Is Greenwave Tech Solutions (GWAV) Stock Down 53% Today? ↗

March 19, 2024

Greenwave Tech Solutions stock is falling on Tuesday following an update on warrants for GWAV stock and other news this morning.

Via InvestorPlace

Nvidia To Rally Around 10%? Here Are 10 Top Analyst Forecasts For Tuesday ↗

March 19, 2024

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.

Via Benzinga

Why Is Ontrak (OTRK) Stock Up 105% Today? ↗

March 19, 2024

Ontrak stock is on the rise Tuesday as OTRK investors are excited about an upcoming live fireside chat set for later today.

Via InvestorPlace

Why Fusion Pharmaceuticals Shares Are Trading Higher By Around 95%; Here Are 20 Stocks Moving Premarket ↗

March 19, 2024

Shares of Fusion Pharmaceuticals Inc. (NASDAQ: FUSN) rose sharply in today’s pre-market trading after the company agreed to be acquired by AstraZeneca for around $2 billion in cash.

Via Benzinga

Why Is Fusion Pharmaceuticals (FUSN) Stock Up 101% Today? ↗

March 19, 2024

Fusion Pharmaceuticals stock is rising higher on Tuesday as AstraZeneca agrees to acquire FUSN for $21 per share with a CVR of $3.

Via InvestorPlace

US Stocks Poised For Lower Open As Fed Jitters Dampen Tech Hopes; Oil Rally Pauses, Bitcoin Slides 8% ↗

March 19, 2024

Interest-rate concerns seem to be impacting market sentiment as stock futures indicate a slightly lower opening on Tuesday.

Via Benzinga

Topics Economy

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday ↗

March 19, 2024

Pre-market stock movers are worth diving into on Tuesday as we check out all of the hottest news worth reading about this morning!

Via InvestorPlace

< Previous 1 2 3 4 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.